Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-05 Purchase |
2025-03-07 6:05 pm |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
824,041 | $30.75 | $25,342,965 | 11,189,693 (Indirect) |
View |
| 2024-10-18 Purchase |
2024-10-22 4:20 pm |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,200,000 | $44.75 | $53,700,000 | 10,365,652 (Indirect) |
View |
| 2024-08-09 Sale |
2024-08-13 5:03 pm |
AN2 Therapeutics Inc. | ANTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
3,525,094 | $1.08 | $3,807,102 | 300,853 (Indirect) |
View |
| 2024-06-27 Purchase |
2024-07-01 9:29 pm |
Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
13,008,546 | $3.84 | $49,952,817 | 5,417,638 (Indirect) |
View |
| 2024-04-02 Purchase |
2024-04-04 4:15 pm |
Boundless Bio Inc. | BOLD | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
312,500 | $16 | $5,000,000 | 295,844 (Indirect) |
View |
| 2024-03-25 Purchase |
2024-03-27 7:37 pm |
ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,401,299 | $9.4836 | $13,289,410 | 10,860,977 (Indirect) |
View |
| 2024-03-21 Purchase |
2024-03-25 8:48 pm |
LENZ Therapeutics Inc. | LENZ | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
998,009 | $15.03 | $15,000,075 | 792,288 (Indirect) |
View |
| 2024-02-09 Purchase |
2024-02-13 4:33 pm |
PepGen Inc. | PEPG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
2,557,593 | $10.64 | $27,212,790 | 10,689,545 (Indirect) |
View |
| 2023-09-21 Purchase |
2023-09-25 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director |
2,700,000 | $3.0309 | $8,183,526 | 9,459,678 (Indirect) |
View |
| 2023-08-29 Purchase |
2023-08-31 5:26 pm |
ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director |
3,750,000 | $6.2 | $23,250,000 | 6,759,678 (Indirect) |
View |
| 2023-08-18 Purchase |
2023-08-22 5:01 pm |
AN2 Therapeutics Inc. | ANTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
1,777,778 | $9 | $16,000,002 | 5,551,295 (Indirect) |
View |
| 2023-07-21 Purchase |
2023-07-25 4:30 pm |
Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
5,161,290 | $7.75 | $39,999,998 | 14,932,063 (Indirect) |
View |
| 2023-07-19 Purchase |
2023-07-21 4:31 pm |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
495,008 | $12.46 | $6,167,800 | 9,668,878 (Indirect) |
View |
| 2023-03-28 Purchase |
2023-03-30 5:03 pm |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
509,145 | $29.07 | $14,798,693 | 7,856,612 (Indirect) |
View |
| 2023-03-23 Purchase |
2023-03-27 5:01 pm |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
498,556 | $26.99 | $13,457,372 | 7,347,467 (Indirect) |
View |
| 2022-11-17 Purchase |
2022-11-21 4:31 pm |
Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
3,389,500 | $12.5 | $42,368,750 | 426,302 (Indirect) |
View |
| 2022-10-17 Purchase |
2022-10-19 4:32 pm |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,640,000 | $36.5 | $59,860,000 | 6,848,911 (Indirect) |
View |
| 2022-08-03 Purchase |
2022-08-05 4:06 pm |
AN2 Therapeutics Inc. | ANTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
1,909 | $7.5067 | $14,330 | 3,773,517 (Indirect) |
View |
| 2022-07-26 Purchase |
2022-07-28 5:16 pm |
AN2 Therapeutics Inc. | ANTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
23,219 | $7.7813 | $180,675 | 3,771,608 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-27 Option Award |
2024-07-01 9:29 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
5,259,872 | $0 | 5,417,638 (Indirect) |
View |
| 2024-06-26 Option Award |
2024-06-28 6:14 pm |
N/A 2034-06-25 |
Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
10,000 | $0 | 10,000 (Indirect) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:35 pm |
N/A 2034-06-25 |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
10,850 | $0 | 9,176,502 (Indirect) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:36 pm |
N/A 2034-06-19 |
Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
20,275 | $0 | 20,275 (Indirect) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:13 pm |
N/A 2034-06-19 |
ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
40,000 | $0 | 40,000 (Indirect) |
View |
| 2024-06-20 Option Award |
2024-06-21 4:14 pm |
N/A 2034-06-19 |
PepGen Inc. | PEPG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
13,000 | $0 | 13,000 (Indirect) |
View |
| 2024-06-10 Option Award |
2024-06-10 5:26 pm |
N/A 2034-06-09 |
Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
25,000 | $0 | 25,000 (Indirect) |
View |
| 2024-05-24 Option Award |
2024-05-24 7:56 pm |
N/A 2034-05-23 |
Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
17,500 | $0 | 17,500 (Indirect) |
View |
| 2024-04-11 Option Award |
2024-04-15 4:15 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
3,530,000 | $8.5 | 8,340,508 (Indirect) |
View |
| 2024-04-02 Conversion |
2024-04-04 4:15 pm |
N/A N/A |
Boundless Bio Inc. | BOLD | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
38,296,702 | $0 | 295,844 (Indirect) |
View |
Ownership |
2024-03-27 8:16 pm |
N/A N/A |
Boundless Bio Inc. | BOLD | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
0 | $0 | 1,868,131 (Indirect) |
View |
| 2024-03-21 Option Award |
2024-03-25 8:48 pm |
2024-03-21 2027-10-30 |
LENZ Therapeutics Inc. | LENZ | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
3,343,318 | $0 | 792,288 (Indirect) |
View |
| 2024-02-19 Equity Swap |
2024-02-20 8:07 pm |
N/A N/A |
Icosavax Inc. | ICVX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
5,969,108 | $0 | 0 (Indirect) |
View |
| 2023-08-09 Equity Swap |
2023-08-09 5:00 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Former 10% owners and Director Director |
7,856,612 | $0 | 0 (Indirect) |
View |
| 2023-06-27 Option Award |
2023-06-28 9:00 pm |
N/A 2033-06-26 |
ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director |
40,000 | $0 | 40,000 (Indirect) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:15 pm |
N/A 2033-06-13 |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
12,500 | $0 | 12,500 (Indirect) |
View |
| 2023-06-06 Option Award |
2023-06-13 4:21 pm |
N/A 2033-06-05 |
Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
25,000 | $0 | 25,000 (Indirect) |
View |
| 2023-05-18 Option Award |
2023-05-22 5:22 pm |
N/A 2033-05-17 |
Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
10,000 | $0 | 10,000 (Indirect) |
View |
| 2022-11-17 Conversion |
2022-11-21 4:31 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
4,925,218 | $0 | 426,302 (Indirect) |
View |
| 2022-11-14 Option Award |
2022-11-16 7:33 pm |
N/A 2032-11-13 |
Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
35,235 | $0 | 35,235 (Indirect) |
View |
| 2022-11-08 Option Award |
2022-11-10 6:00 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director |
3,009,678 | $0 | 902,904 (Indirect) |
View |
Ownership |
2022-11-09 8:30 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 1,421,008 (Indirect) |
View |